Get started
Author

P.M. Nederlof

Predicting response to alkylating chemotherapy in breast cancer patients using array comparative genomic hybridization.
2009 · MA Vollebergh, PM Nederlof, et al. · Cancer Research · 9
Abstract PD07-07: Indicators of Homologous Recombination Deficiency in Breast Cancer and Association with Response to Neoadjuvant Chemotherapy
2010 · EH Lips, L Mulder, et al. · Cancer Research · 1
Abstract P4-12-03: Estrogen receptor-positive breast cancer in BRCA1 mutation carriers shows a BRCAness profile, suggesting sensitivity to drugs targeting homologous recombination deficiency
2017 · EH Lips, R Debipersad, et al. · Cancer Research
Abstract PD1-07: Comprehensive characterization of matched pre-treatment biopsies and residual disease of doxorubicin treated breast cancer
2017 · EH Lips, M Hoogstraat, et al. · Cancer Research
Organ-Independent Prediction of Brca1 Mutation-Like Status Based on Copy Number Gains and Losses in Breast and Ovarian Cancer
2014 · P. Schouten, D.J. Vis, et al. · Annals of Oncology
PD03-08: BRCA1-Like Triple Negative Tumors: Clinicopathological Variables and Chemosensitivity to Alkylating Agents.
2011 · J Wesseling, EH Lips, et al. · Cancer Research
Abstract PD01-04: Histological Features of ER-Low, HER2-Negative Breast Cancer Predict Response to High Dose, Platinum-Based Chemotherapy
2010 · J Wesseling, MA Vollebergh, et al. · Cancer Research
10 Homologous recombination deficiency in breast cancer and association with response to neo-adjuvant chemotherapy
2010 · E.H. Lips, L. Mulder, et al. · European Journal of Cancer Supplements
1202 POSTER Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer
2007 · W.E. Hoogendoorn, H. Hollema, et al. · European Journal of Cancer Supplements
Specific chromosomal imbalance in breast carcinomas as a marker for breast cancer susceptibility
2007 · Peter Devilee, P.M. Nederlof, et al.
P195 Pulmonary Carcinoma Following Head and Neck Squamous Cell Carcinoma: Differentiation of Metastasis and Second Primary Tumors Using Loss of Heterozygosity and TP53 Analysis
2006 · T. Geurts, A. Balm, et al. · Archives of Otolaryngology - Head and Neck Surgery
Identification of BRCA1 mutation carriers in high-risk breast and ovarian cancer families using genetic profiling
2005 · Frans B.L. Hogervorst, P.M. Nederlof, et al.
Identificatie van draagsters van de BRCA1 mutatie met behulp van genetische profielen in families met een hoog risico op borstkanker en eierstokkanker
2005 · F.B.L. Hogervorst, P.M. Nederlof, et al.
Pathological and molecular characteristics of tamoxifen-induced endometrial tumors
2002 · H. Hollema, F.E. van Leeuwen, et al.
Pathologische en moleculaire kenmerken van door tamoxifen geïnduceerde baarmoederslijmvliestumoren
2002 · H. Hollema, F.E. van Leeuwen, et al.
Genetic profiling of tumors from patients with a genetic susceptibility for breast cancer
2001 · P.M. Nederlof, Laura van ‘t Veer, et al.
Genetische profilering van tumoren van patiënten met een genetische gevoeligheid voor borstkanker
2001 · P.M. Nederlof, Laura van ‘t Veer, et al.
Works count: 17
Citation count: 10
H-index: 1
I10-index:
Year
Topic
Type